HopeStage
Back to all studies
CompletedNCT04055467

Brain Imaging of Nicotine Receptors During a Quit Attempt

About this titleRead the official source — NCT04055467
Medication studyAges 21–50United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 50 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 16, 2019
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 50 Years
Official registry ID
NCT04055467
Official title
Show the full official title

Brain Imaging of Nicotinic Acetylcholine Receptors in Tobacco Users and Nonusers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide).

Who was this study for?

Listed age limits: 21 years to 50 years.

Want to explore more studies?

Explore studies